Management of patients with recurrent/advanced cervical cancer beyond first line platinum regimens: Where do we stand? A literature review
Year: 2016
Type: review
Language: English
Subfield: Obstetrics and Gynecology
Field: Medicine
Domain: Health Sciences
Keywords: recurrent cervical cancer, metastatic cervical cancer, second-line chemotherapy, platinum resistance, cisplatin, paclitaxel, topotecan, vinorelbine, gemcitabine, bevacizumab, angiogenesis inhibitors, tyrosine kinase inhibitors, mTOR inhibitors, PIK3CA mutation, immune checkpoint inhibitors, PD-1, CTLA-4, targeted therapy, palliative chemotherapy
Open Access status: closed
Funder: University of Ioannina
OpenAlex ID: W2553088533
